These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20415649)

  • 1. MicroRNA-21: from cancer to cardiovascular disease.
    Jazbutyte V; Thum T
    Curr Drug Targets; 2010 Aug; 11(8):926-35. PubMed ID: 20415649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA and vascular cell movement.
    Yue J
    Adv Drug Deliv Rev; 2011 Jul; 63(8):616-22. PubMed ID: 21241758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-21 in cardiovascular disease.
    Cheng Y; Zhang C
    J Cardiovasc Transl Res; 2010 Jun; 3(3):251-5. PubMed ID: 20560046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA regulation as a therapeutic strategy for cardiovascular disease.
    Montgomery RL; van Rooij E
    Curr Drug Targets; 2010 Aug; 11(8):936-42. PubMed ID: 20415653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA biogenesis pathway as a therapeutic target for human disease and cancer.
    De Santa F; Iosue I; Del Rio A; Fazi F
    Curr Pharm Des; 2013; 19(4):745-64. PubMed ID: 23016856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and function of miRNA-21 in health and disease.
    Kumarswamy R; Volkmann I; Thum T
    RNA Biol; 2011; 8(5):706-13. PubMed ID: 21712654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting microRNA expression to regulate angiogenesis.
    Kuehbacher A; Urbich C; Dimmeler S
    Trends Pharmacol Sci; 2008 Jan; 29(1):12-5. PubMed ID: 18068232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles of microRNAs in the molecular responses to hypoxia.
    Crosby ME; Devlin CM; Glazer PM; Calin GA; Ivan M
    Curr Pharm Des; 2009; 15(33):3861-6. PubMed ID: 19925433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34a: role in cancer and cardiovascular disease.
    Chen X; Zhou JY; Zhou JY
    Curr Drug Targets; 2014 Apr; 15(4):361-73. PubMed ID: 24438466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-224: as a potential target for miR-based therapy of cancer.
    Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
    Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-143/-145 in Cardiovascular Diseases.
    Zhao W; Zhao SP; Zhao YH
    Biomed Res Int; 2015; 2015():531740. PubMed ID: 26221598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Cancer: the 22nd Hiroshima Cancer Seminar/the 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima.
    Tahara H; Kay MA; Yasui W; Tahara E
    Jpn J Clin Oncol; 2013 May; 43(5):579-82. PubMed ID: 23487440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
    Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
    BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
    Chen F; Hu SJ
    J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-223: An inflammatory oncomiR enters the cardiovascular field.
    Taïbi F; Metzinger-Le Meuth V; Massy ZA; Metzinger L
    Biochim Biophys Acta; 2014 Jul; 1842(7):1001-9. PubMed ID: 24657505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle microRNA transfer in cardiovascular disease.
    Das S; Halushka MK
    Cardiovasc Pathol; 2015; 24(4):199-206. PubMed ID: 25958013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-based therapeutic approaches in the cardiovascular system.
    Fiedler J; Gupta SK; Thum T
    Cardiovasc Ther; 2012 Feb; 30(1):e9-e15. PubMed ID: 20946325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-210 and its theranostic potential.
    Ren CX; Leng RX; Fan YG; Pan HF; Wu CH; Ye DQ
    Expert Opin Ther Targets; 2016 Nov; 20(11):1325-1338. PubMed ID: 27359286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.